Endovascular Brachytherapy for the Treatment of Renal Artery In-Stent Restenosis Using a β-Emitting Source: A Report of Five PatientsChristopher D. Jahraus, Ali S. Meigooni, William St Clair et al.|Southern Medical Journal|2003Cited by 13
Lymphocyte subset abnormalities in early severe scleroderma favor a Th2 phenotype and are not altered by prior immunosuppressive therapyAnkoor R. Shah, Keith M. Sullivan, Jan Storek et al.|Lara D. Veeken|2022Cited by 10
Endovascular brachytherapy for the treatment of renal artery in-stent restenosis using a β-emitting source: A series of 15 patientsBarbara A. Williams, Ali S. Meigooni, William St Clair et al.|International Journal of Radiation Oncology*Biology*Physics|2004Cited by 2